Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma

Purpose. It has been reported that Th2 cytokines downregulate antitumor immunity, while activation of type T cells promotes antitumor immunity. The aim of this paper was to evaluate host immunity in liver cirrhosis (LC) patients with advanced hepatocellular carcinoma (aHCC) receiving sorafenib thera...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nagai, Hidenari, Mukozu, Takanori, Matsui, Daigo, Kanekawa, Takenori, Kanayama, Masahiro, Wakui, Noritaka, Momiyama, Kouichi, Shinohara, Mie, Iida, Kazunari, Ishii, Koji, Igarashi, Yoshinori, Sumino, Yasukiyo
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3359796/
https://ncbi.nlm.nih.gov/pubmed/22666283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/607851
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados